A composite scale using MRI-defined cerebral lesions and atrophy to assess the therapeutic effect of glatiramer acetate in multiple sclerosis

被引：0
|
作者：
Tauhid, S. [1 ]
Kim, G. [1 ]
Dupuy, S. L. [1 ]
Tummala, S. [1 ]
Khalid, F. [1 ]
Healy, B. C. [2 ]
Bakshi, R. [1 ]
机构：
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Lab Neuroimaging Res, Boston, MA 02115 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Neurol,Partners MS Ctr, Boston, MA 02115 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P980
引用
收藏
页码：499 / 500
页数：2
相关论文
共 42 条
  • [1] An MRI-Defined Measure of Cerebral Lesion Severity to Assess the Therapeutic Effect of Glatiramer Acetate in Multiple Sclerosis
    Kim, Gloria
    Tauhid, Shahamat
    Dupuy, Sheena
    Tummala, Subhash
    Khalid, Fariha
    Healy, Brian
    Bakshi, Rohit
    NEUROLOGY, 2016, 86
  • [2] Identifying Phenotypes Based on MRI-Defined Cerebral Lesions and Atrophy in Patients with Multiple Sclerosis
    Tauhid, Shahamat
    Neema, Mohit
    Ceccarelli, Antonia
    Healy, Brian
    Arora, Ashish
    Weiner, Howard
    Bakshi, Rohit
    NEUROLOGY, 2013, 80
  • [3] An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis
    Gloria Kim
    Shahamat Tauhid
    Sheena L. Dupuy
    Subhash Tummala
    Fariha Khalid
    Brian C. Healy
    Rohit Bakshi
    Journal of Neurology, 2016, 263 : 531 - 538
  • [4] An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis
    Kim, Gloria
    Tauhid, Shahamat
    Dupuy, Sheena L.
    Tummala, Subhash
    Khalid, Fariha
    Healy, Brian C.
    Bakshi, Rohit
    JOURNAL OF NEUROLOGY, 2016, 263 (03) : 531 - 538
  • [5] Exploring the effect of glatiramer acetate on cerebral gray matter atrophy in multiple sclerosis
    AbdelRazek, Mahmoud A.
    Tummala, Subhash
    Khalid, Fariha
    Tauhid, Shahamat
    Jalkh, Youmna
    Khalil, Samar
    Hurwitz, Shelley
    Zurawski, Jonathan
    Bakshi, Rohit
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 444
  • [6] Assessment of the effect of glatiramer acetate on cerebral gray matter atrophy in multiple sclerosis
    Tummala, Subhash
    Tauhid, Shahamat
    Hurwitz, Shelley
    Bakshi, Rohit
    NEUROLOGY, 2017, 88
  • [7] An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2
    Bakshi, Rohit
    Neema, Mohit
    Tauhid, Shahamat
    Healy, Brian C.
    Glanz, Bonnie I.
    Kim, Gloria
    Miller, Jennifer
    Berkowitz, Julia L.
    Bove, Riley
    Houtchens, Maria K.
    Severson, Christopher
    Stankiewicz, James M.
    Stazzone, Lynn
    Chitnis, Tanuja
    Guttmann, Charles R. G.
    Weiner, Howard L.
    Ceccarelli, Antonia
    NEUROREPORT, 2014, 25 (14) : 1156 - 1161
  • [8] Segmentation of MRI-defined multiple sclerosis lesions using FLAIR-MTC and MR flow images
    Bedell, BJ
    Narayana, PA
    Wolinsky, JS
    NEUROLOGY, 1996, 46 (02) : 70004 - 70004
  • [9] MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis
    Tauhid, Shahamat
    Neema, Mohit
    Healy, Brian C.
    Weiner, Howard L.
    Bakshi, Rohit
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 346 (1-2) : 250 - 254
  • [10] MRI-Defined Corpus Callosal Atrophy in Multiple Sclerosis: A Comparison of Volumetric Measurements, Corpus Callosum Area and Index
    Granberg, Tobias
    Bergendal, Gosta
    Shams, Sara
    Aspelin, Peter
    Kristoffersen-Wiberg, Maria
    Fredrikson, Sten
    Martola, Juha
    JOURNAL OF NEUROIMAGING, 2015, 25 (06) : 996 - 1001
12345